Introduction

This page provides a comprehensive analysis of the known insider trading history of John C Landgraf. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate John C Landgraf has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ABT / Abbott Laboratories Executive Vice President 108,972
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by John C Landgraf. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by John C Landgraf as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2015-03-03 2015-02-27 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -11,530 108,972 -9.57 47.61 -548,943 5,188,157
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 165,292 165,292
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 23,457 120,502 24.17
2015-02-24 2014-06-03 4/A ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -16,289 97,045 -14.37 39.80 -648,302 3,862,391
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -11,956 0 -100.00
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -6,247 0 -100.00
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -16,284 97,050 -14.37 39.80 -648,103 3,862,590
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 11,956 113,334 11.79 32.16 384,456 3,644,357
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 6,247 101,378 6.57 31.43 196,315 3,185,854
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -807 95,131 -0.84 39.40 -31,797 3,748,257
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -6,307 95,938 -6.17 39.40 -248,496 3,779,957
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -192 102,245 -0.19 39.39 -7,563 4,027,431
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,377 102,437 -1.33 39.38 -54,226 4,033,969
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -8,610 103,814 -7.66 39.37 -338,976 4,087,157
2014-03-04 2014-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -15,307 112,424 -11.98 39.79 -609,066 4,473,351
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 154,953 154,953
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 25,310 127,731 24.71
2014-02-19 2014-02-18 4 ABT ABBOTT LABORATORIES
Option(right to buy) 		M - Exercise 1,583 0 -100.00
2014-02-19 2014-02-18 4 ABT ABBOTT LABORATORIES
Common Shares without par value 		S - Sale -600 102,421 -0.58 39.10 -23,463 4,005,173
2014-02-19 2014-02-18 4 ABT ABBOTT LABORATORIES
Common Shares without par value 		S - Sale -983 103,021 -0.95 39.10 -38,436 4,028,224
2014-02-19 2014-02-18 4 ABT ABBOTT LABORATORIES
Common Shares without par value 		M - Exercise 1,583 104,004 1.55 35.03 55,452 3,643,260
2014-02-11 2014-02-07 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -21,972 0 -100.00
2014-02-11 2014-02-07 4 ABT ABBOTT LABORATORIES
Common Shares without par value 		S - Sale -11,572 102,421 -10.15 36.96 -427,701 3,785,480
2014-02-11 2014-02-07 4 ABT ABBOTT LABORATORIES
Common Shares without par value 		S - Sale -10,400 113,993 -8.36 36.95 -384,280 4,212,041
2014-02-11 2014-02-07 4 ABT ABBOTT LABORATORIES
Common Shares without par value 		M - Exercise 21,972 124,393 21.45 32.16 706,529 3,999,969
2013-12-20 2013-11-27 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift -2,885 102,421 -2.74
2013-10-24 3 ABT ABBOTT LABORATORIES
Common shares without par value 		105,306
2013-10-24 3 ABT ABBOTT LABORATORIES
Common shares without par value 		18,398
2013-10-24 3 ABT ABBOTT LABORATORIES
Common shares without par value 		166
2013-03-01 2013-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -13,414 105,078 -11.32 34.26 -459,564 3,599,972
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -266 118,492 -0.22 34.78 -9,252 4,121,270
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -2,800 118,758 -2.30 34.78 -97,390 4,130,641
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -8,616 121,558 -6.62 35.08 -302,249 4,264,255
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 165,000 165,000
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 31,700 130,174 32.19
2013-02-13 2012-12-07 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift 11,614 11,614
2012-12-14 2012-11-07 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift -85 98,474 -0.09
2012-12-14 2012-11-06 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift -200 98,559 -0.20
2012-12-14 2012-10-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift -90 98,759 -0.09
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 21,972 21,972
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 11,956 11,956
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -7,057 0 -100.00
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -17,920 0 -100.00
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -13,588 0 -100.00
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -33,928 98,849 -25.55 66.92 -2,270,462 6,614,975
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 7,057 132,777 5.61 53.12 374,868 7,053,114
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 31,508 125,720 33.44 53.19 1,675,911 6,687,047
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 6,247 6,247
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -7,156 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -1,823 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -12,835 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -13,439 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -4,935 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -13,270 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -23,000 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -63,800 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -130,944 94,212 -58.16 65.50 -8,576,832 6,170,886
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -6,247 225,156 -2.70 65.40 -408,554 14,725,202
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 7,156 231,403 3.19 51.21 366,459 11,850,148
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 1,823 224,247 0.82 55.57 101,304 12,461,406
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 12,835 222,424 6.12 58.71 753,543 13,058,513
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 13,439 209,589 6.85 54.30 729,738 11,380,683
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 4,935 196,150 2.58 53.12 262,147 10,419,488
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 13,270 191,215 7.46 53.19 705,831 10,170,726
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 23,000 177,945 14.84 44.16 1,015,680 7,858,051
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 63,800 154,945 70.00 46.34 2,956,492 7,180,151
2012-03-21 2012-03-19 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -30,000 23,000 -56.60
2012-03-21 2012-03-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -30,000 91,145 -24.76 60.00 -1,800,000 5,468,700
2012-03-21 2012-03-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 30,000 121,145 32.91 44.16 1,324,800 5,349,763
2012-03-14 2012-03-12 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -30,000 53,000 -36.14
2012-03-14 2012-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,900 91,145 -2.04 58.16 -110,506 5,301,084
2012-03-14 2012-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -28,100 93,045 -23.20 58.16 -1,634,296 5,411,497
2012-03-14 2012-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 30,000 121,145 32.91 44.16 1,324,800 5,349,763
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,446 91,145 -1.56 56.72 -82,024 5,170,200
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -7,441 92,591 -7.44 56.72 -422,054 5,251,762
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -200 100,032 -0.20 56.72 -11,344 5,673,885
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -100 100,232 -0.10 56.72 -5,672 5,685,179
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -7,700 100,332 -7.13 56.72 -436,752 5,690,931
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -10,579 108,032 -8.92 57.04 -603,426 6,162,145
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 55,000 55,000
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 30,500 118,611 34.62
2006-02-22 2006-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -310 93,675 -0.33 43.86 -13,597 4,108,586
2006-02-22 2006-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -1,146 67,485 -1.67 44.15 -50,596 2,979,463
2006-02-22 2006-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 83,000 83,000
2006-02-22 2006-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 26,500 93,985 39.27 44.16 1,170,240 4,150,378
2004-08-05 3 ABT ABBOTT LABORATORIES
Common shares without par value 		61,305
2004-08-05 3 ABT ABBOTT LABORATORIES
Common shares without par value 		14,238
2004-08-05 3 ABT ABBOTT LABORATORIES
Common shares without par value 		823
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)